Literature DB >> 30391741

Influence of lipopolysaccharide on diazepam-modified loss of righting reflex duration by pentobarbital treatment in mice.

Yoshihisa Kitamura1, Shiho Hongo2, Yoshiaki Yamashita2, Shinpei Yagi2, Kanami Otsuki2, Akihisa Miki2, Ayumi Okada2, Soichiro Ushio2, Satoru Esumi2, Toshiaki Sendo2.   

Abstract

Benzodiazepine receptor agonists are widely prescribed therapeutic agents, alter gamma-aminobutyric acid (GABA)A receptor function, and have hypnotic, anxiolytic, anticonvulsant, and antispastic effects. GABAA receptor activity increases under systemic inflammatory conditions. We investigated the effect of benzodiazepine receptor agonists on pentobarbital-induced loss of righting reflex (LORR) duration using a mouse model of lipopolysaccharide (LPS)-induced inflammation. We assessed pentobarbital-induced LORR duration 24 h after LPS treatment in mice. Additionally, we examined the microglial response by immunohistochemistry and serum IL-6 and TNF-α concentrations in mice. LPS treatment significantly increased the duration of pentobarbital-induced LORR in mice treated with benzodiazepine receptor agonists (diazepam and brotizolam) and a GABAA receptor agonist (muscimol) compared to that of mice treated with vehicle. These effects were blocked by bicuculline, a GABAA receptor antagonist. LPS significantly increased the number of ionized calcium binding adapter molecule-1-positive hippocampal cells 2 and 24 h after treatment. The enhancing effect of diazepam in LPS-treated mice was significantly reduced by minocycline. These findings suggest that LPS enhances pentobarbital-induced LORR duration in mice treated with benzodiazepine via GABAA receptor activity.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Benzodiazepine receptor agonist; GABA(A) receptor; Inflammation; Lipopolysaccharide; Microglia; Minocycline

Mesh:

Substances:

Year:  2018        PMID: 30391741     DOI: 10.1016/j.ejphar.2018.10.049

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Yokukansan suppresses neuroinflammation in the hippocampus of mice and decreases the duration of lipopolysaccharide- and diazepam-mediated loss of righting reflex induced by pentobarbital.

Authors:  Kei Kawada; Tomoaki Ishida; Kohei Jobu; Shumpei Morisawa; Tetsushi Kawazoe; Motoki Nishida; Satomi Nishimura; Naohisa Tamura; Saburo Yoshioka; Mitsuhiko Miyamura
Journal:  J Nat Med       Date:  2022-03-08       Impact factor: 2.343

2.  Anxiolytic-like effects of hochuekkito in lipopolysaccharide-treated mice involve interleukin-6 inhibition.

Authors:  Soichiro Ushio; Yudai Wada; Mizuki Nakamura; Daiki Matsumoto; Kota Hoshika; Shoya Shiromizu; Naohiro Iwata; Satoru Esumi; Makoto Kajizono; Yoshihisa Kitamura; Toshiaki Sendo
Journal:  Front Pharmacol       Date:  2022-08-12       Impact factor: 5.988

3.  The Dual Role of the GABAA Receptor in Peripheral Inflammation and Neuroinflammation: A Study in Hyperammonemic Rats.

Authors:  Michele Malaguarnera; Tiziano Balzano; Mari Carmen Castro; Marta Llansola; Vicente Felipo
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.